$493 Million is the total value of Samsara BioCapital, LLC's 44 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 41.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JYAC | New | Jiya Acquisition Corp | $507,041,000 | – | 5,223 | +100.0% | 50.99% | – |
| NKTX | Nkarta, Inc. | $125,073,000 | +104.5% | 2,034,703 | 0.0% | 12.58% | -26.3% | |
| KDNY | New | Chinook Therapeutics Inc | $50,251,000 | – | 3,168,388 | +100.0% | 5.05% | – |
| FMTX | Sell | Forma Therapeutics Holdings, Inc. | $49,507,000 | -33.4% | 1,418,529 | -4.9% | 4.98% | -76.0% |
| STRO | Sutro BioPharma Inc | $36,377,000 | +116.0% | 1,675,579 | 0.0% | 3.66% | -22.1% | |
| SYRS | Buy | Syros Pharmaceuticals Inc | $21,837,000 | +88.1% | 2,189,199 | +55.5% | 2.20% | -32.2% |
| ALLK | Sell | Allakos Inc | $20,476,000 | +30.7% | 146,259 | -24.0% | 2.06% | -52.9% |
| SWTX | Sell | Springworks Therapeutics Inc | $19,042,000 | +0.4% | 262,572 | -34.0% | 1.92% | -63.8% |
| ISEE | Sell | Iveric Bio, Inc. | $16,396,000 | -13.7% | 2,372,476 | -29.6% | 1.65% | -68.9% |
| ODT | Odonate Therapeutics Inc | $15,656,000 | +43.0% | 815,421 | 0.0% | 1.57% | -48.5% | |
| ICPT | Intercept Pharmaceuticals Inc | $9,971,000 | -40.4% | 403,688 | 0.0% | 1.00% | -78.5% | |
| ACRS | Sell | Aclaris Therapeutics, Inc. | $8,816,000 | +59.3% | 1,362,612 | -36.7% | 0.89% | -42.6% |
| VRNA | Verona Pharma PLC.spons ads | $7,778,000 | +12.2% | 1,111,112 | 0.0% | 0.78% | -59.6% | |
| CVAC | Sell | CureVac N.V. | $7,727,000 | -55.2% | 95,318 | -74.3% | 0.78% | -83.8% |
| BCEL | Sell | Atreca Inc | $7,670,000 | -11.1% | 474,943 | -23.1% | 0.77% | -68.0% |
| AGLE | Aeglea BioTherapeutics, Inc. | $6,955,000 | +11.0% | 883,720 | 0.0% | 0.70% | -60.0% | |
| COGT | New | Cogent Biosciences Inc | $6,614,000 | – | 588,961 | +100.0% | 0.66% | – |
| RYTM | Sell | Rhythm Pharmaceuticals Inc | $5,977,000 | +17.4% | 201,046 | -14.4% | 0.60% | -57.6% |
| EQ | Equillium, Inc. | $5,747,000 | -7.3% | 1,074,285 | 0.0% | 0.58% | -66.6% | |
| BCTG | BCTG Acquisition Corp | $5,720,000 | +10.4% | 500,000 | 0.0% | 0.58% | -60.2% | |
| PANAU | Panacea Acquisition Corp.unit | $5,104,000 | +6.3% | 400,000 | 0.0% | 0.51% | -61.7% | |
| ALPN | Sell | Alpine Immune Sciences Inc | $5,030,000 | +15.8% | 399,190 | -19.2% | 0.51% | -58.3% |
| KRON | New | Kronos Bio Inc | $4,966,000 | – | 166,250 | +100.0% | 0.50% | – |
| KALA | Buy | Kala Pharmaceuticals Inc | $4,076,000 | +20.4% | 601,162 | +33.2% | 0.41% | -56.6% |
| ALBO | Albireo Pharma, Inc. | $3,751,000 | +12.4% | 100,000 | 0.0% | 0.38% | -59.5% | |
| RCKT | Sell | Rocket Pharmaceuticals Inc | $3,497,000 | +53.5% | 63,770 | -36.0% | 0.35% | -44.6% |
| FULC | Fulcrum Therapeutics, Inc. | $3,444,000 | +47.7% | 294,118 | 0.0% | 0.35% | -46.8% | |
| NVAX | Buy | Novavax, Inc. | $3,363,000 | +43.3% | 30,160 | +39.2% | 0.34% | -48.4% |
| BLSA | New | BCLS Acquisition Corp | $3,342,000 | – | 300,000 | +100.0% | 0.34% | – |
| VTGN | New | Vistagen Therapeutics Inc | $3,182,000 | – | 1,640,368 | +100.0% | 0.32% | – |
| ALVR | Sell | Allovir, Inc | $3,165,000 | +26.4% | 82,336 | -9.6% | 0.32% | -54.4% |
| CHFWU | New | Consonance HFW Acquisition Co | $3,141,000 | – | 300,000 | +100.0% | 0.32% | – |
| AVDL | New | Avadel Pharmaceuticals PLCspons adr | $2,901,000 | – | 434,250 | +100.0% | 0.29% | – |
| LSAQ | New | Lifesci Acquisition II Corp | $2,134,000 | – | 200,000 | +100.0% | 0.22% | – |
| GERN | Sell | Genron Corporation | $1,948,000 | -26.9% | 1,224,870 | -20.0% | 0.20% | -73.6% |
| HOOK | Buy | Hookipa Pharma Inc | $1,438,000 | +30.3% | 129,660 | +11.2% | 0.14% | -52.9% |
| KALV | Sell | KalVista Pharmaceuticals Inc | $1,277,000 | +20.6% | 67,270 | -20.0% | 0.13% | -56.6% |
| SBTX | New | Silverback Therapeutics Inc | $1,159,000 | – | 25,000 | +100.0% | 0.12% | – |
| BNTX | Sell | BioNTech SEspons ads | $880,000 | +0.1% | 10,795 | -15.0% | 0.09% | -64.1% |
| KDMN | New | Kadmon Hldgs Inc | $685,000 | – | 165,000 | +100.0% | 0.07% | – |
| Catabasis Pharmaceuticals Inc | $642,000 | -65.4% | 300,000 | 0.0% | 0.06% | -87.5% | ||
| NGM | Sell | NGM Biopharmaceuticals, Inc. | $552,000 | -4.8% | 18,225 | -50.0% | 0.06% | -65.4% |
| AMRN | Amarin Corp PLCspons adr new | $122,000 | +16.2% | 25,000 | 0.0% | 0.01% | -58.6% | |
| UROV | Exit | Urovant Sciences Ltd | $0 | – | -157,480 | -100.0% | -0.41% | – |
| SPRO | Exit | Spero Therapeutics, Inc. | $0 | – | -160,000 | -100.0% | -0.50% | – |
| AIMT | Exit | Aimmune Therapeutics, Inc. | $0 | – | -58,142 | -100.0% | -0.56% | – |
| UMRX | Exit | Unum Therapeutics, Inc. | $0 | – | -5,681,818 | -100.0% | -3.71% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Intercept Pharmaceuticals Inc | 20 | Q3 2023 | 24.0% |
| ALLAKOS INC | 20 | Q3 2023 | 23.0% |
| SUTRO BIOPHARMA INC | 20 | Q3 2023 | 10.1% |
| SYROS PHARMACEUTICALS INC | 16 | Q3 2022 | 11.6% |
| ATRECA INC | 16 | Q1 2023 | 7.4% |
| IVERIC BIO INC | 15 | Q2 2023 | 5.5% |
| ACLARIS THERAPEUTICS INC | 15 | Q3 2023 | 4.8% |
| RHYTHM PHARMACEUTICALS INC | 15 | Q3 2023 | 2.4% |
| ODONATE THERAPEUTICS INC | 14 | Q1 2022 | 14.9% |
| SPRINGWORKS THERAPEUTICS INC | 14 | Q4 2022 | 12.1% |
View Samsara BioCapital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR/A | 2023-02-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Samsara BioCapital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.